Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Creo Medical Group Plc | CREO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.50 | 3.10% | 16.625 | 15:14:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 16.125 | 16.00 | 16.625 | 16.625 | 16.125 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 20/11/2024 14:57 by zeus19 This cant be right? Super investor Parob told us this was where to put our money but its been declining since |
Posted at 01/10/2024 20:41 by slicethepie I apologise for repeating this but this poorly handled placing is bad for the uk market in general. For two quality brokers to make such a mess is unacceptable. They both had plenty of time to get their books in the right position and to understand the share register. At a minimum they should refund creo 50% of their fees. I am pretty sure all the investors who got legged over will cut their commission for a few months. |
Posted at 01/10/2024 06:56 by dr biotech Well fair play to two directors (particularly the chair) for putting their money on the line. Would have been nice to see a few others share the pain though.I'm pondering what to do - I'm overly emotionally committed here but its only an average size position. The product is (in my mind) excellent but clearly they are struggling to get people to run with it. Doubling the number of training centres but only seeing a very small increase (25, 4 per month) in the number of users seems to show how difficult it is to get them to change. Its a conservative market and whilst the Creo product is better, its seems that familiarity with legacy instruments is hard to get over. Of the sales I'd like to know how many boxes they have sold and how many disposable scopes - just to get an idea of actual usage. Its seems there a few users who love it and have used it 100+ times, there will be some at the other end too. Obviously also depends on their patients. Could do without the management guff - headline figure says 79% above H1-23, but then say later on that is only 14% above H2-23 because H2 benefitted from a backlog from delayed sales from H1... Picking and choosing your comparators won't convince anyone and just looks disingenuous. Have to feel for the early investors. I've held plenty of disappointing UK bios. There is still hope here, particularly with Intuitive or CMR. Reducing headcount may be necessary - as painful as that is, its better to cut some now than all of them if it fails. Reducing the exec pay is another less painful option. |
Posted at 30/9/2024 22:11 by yasirallrico1 I’m Totally exhausted with this Stock. I’m on of the Early investors and Yet again Another Drain on an already Diluted stock. The Pain is unbearable I feel like I’m Trapped in a vortex and and there’s No way off. We have been fed Lies it’s just Never Ending. |
Posted at 30/9/2024 19:40 by 74tom The fact of the matter is AIM would be far better off without companies like CREO.Retail investors have been strung along whilst the management have pillaged the company for all it's worth. As per page 92 of the last annual report the remuneration taken over the last 2 years is shocking; 4 directors took cumulative salaries of £1,963,392 in 2022 + 2023. If that wasn't enough, they took bonuses of £484k in FY22 and £646k in FY23. They also awarded themselves a combined £1.5m in LTIP shares too! For a company 'attempting' to get to breakeven it's just horrendous greed. |
Posted at 28/9/2024 10:50 by nimbo10 Mention in investors chronicle yesterday, don't have access. |
Posted at 18/9/2024 11:23 by nimbo10 Sure is mega, feel comfortable now no cap in hand for fundraise, which was a major flag for new investors. |
Posted at 16/9/2024 21:25 by dr biotech Fwiw Walbrook (Investor relations) said it could be assumed results were “in line”. Not really sure that they would know otherwise though. |
Posted at 27/8/2024 14:53 by dr biotech I think more engagement can only be a good thing. I think this lot have done OK - they have at least done some Investormeets where your average PI can ask questions and the occasional investor conference. I guess it also takes up management time.Might be some other innocuous reason - CEO/CFO being on holiday over August etc. I guess we'll see when the results do come out. |
Posted at 27/8/2024 13:44 by dr biotech FWIW Investor relations (Walbrook) have said there will not be a trading update before the next results. There is no statutory requirement for one. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
